A Phase 1 Study in Subjects With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT02561962 · COMPLETED

Trial details

NCT number: NCT02561962
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2015-11-20
Primary completion: 2018-11-30
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.